The independent source for health policy research, polling, and news.
KFF’s policy research provides facts and analysis on a wide range of policy issues and public programs.
KFF designs, conducts and analyzes original public opinion and survey research on Americans’ attitudes, knowledge, and experiences with the health care system to help amplify the public’s voice in major national debates.
KFF Health News is a national newsroom that produces in-depth journalism about health issues and is one of the organization’s core operating programs.
This analysis examines Black adults’ attitudes, concerns, and intentions regarding a COVID-19 vaccine. While Black men and women are similar in many of their views, there is a gender gap in some COVID-19 vaccine attitudes and intentions.
The Latest KFF COVID-19 Vaccine Monitor finds a growing share of U.S. adults say they have already gotten at least one dose of the vaccine or want to get vaccinated as soon as possible. Black and Hispanic adults remain more likely to want to wait and see how the vaccine is working for others before getting it themselves.
March 4, 2021 – THE CONVERSATION: Between Us, About Us. is a new campaign to provide Black communities with credible information about the COVID-19 vaccines co-developed by KFF (Kaiser Family Foundation) and the Black Coalition Against COVID.
This report shows about half over the age of 65 say they have already received at least one dose of the vaccine or have scheduled an appointment to do so. It also examines how easy or difficult it has been for people to get an appointment and information about the vaccine, and where the public would most like to receive it.
Despite Optimism about COVID-19 Vaccines in the Future, Half Say They are Frustrated with the Current Situation and Nearly a Quarter are Angry While older Americans are a high-priority group for getting a COVID-19 vaccine, the latest KFF COVID-19 Vaccine Monitor report finds that, among those who have not yet been vaccinated, most people ages 65 and…
As the country broadens COVID-19 vaccine distribution efforts, the latest research from the KFF COVID-19 Vaccine Monitor finds that side effects, including allergic reactions and long-term consequences, are the public’s top concern about getting vaccinated when asked to describe what worries them in their own words.
Nearly a third (31%) of the public says they want to “wait and see” how a COVID-19 vaccine works for others before they would get it, representing a critical group for efforts aimed at boosting vaccinations.
This Policy Watch examines how the 50 states and DC are defining “high-risk medical conditions” for COVID-19 vaccine prioritization, including whether they follow CDC’s recommendations or deviate in some way.
This policy watch looks at the expected ramp up in vaccine supply, and what this could mean for increasing the number of people getting vaccinated.
Just 7% of low-income countries' populations have received at least one dose of a COVID-19 vaccine as of December 20, well behind the 40% target for 2021.
© 2025 KFF